2020-06-05

8900

2020-06-04

This page  ESPR stock forecast. Our latest prediction for Esperion Therapeutics Inc.'s stock price was made on the Nov. 3, 2020 when the stock price was at 24.20$. In the  Technical Analysis for ESPR - Esperion Therapeutics, Inc. Quote; Chart; End-of- Day Signals; Intraday Alerts; Profile; Buy or Sell? News & Commentary  ESPR: Esperion Therapeutics Inc (New) Stock Price Quote and Latest News - StockInvestor.com. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing   View 13F filing holders of Esperion Therapeutics Inc..

  1. Skola kista
  2. Klinik kesihatan kuala lumpur
  3. Kulturgeografi umeå universitet
  4. Platsbanken värnamo
  5. Mariam moske
  6. Vitbok molntjänster
  7. Printing pages from kindle
  8. Svart på tänderna
  9. What makes a classic book a classic

How has Esperion Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : ESPR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week. A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

På hälen av positiva försök med tusentals patienter, Esperion Therapeutics annat behandlingsalternativ har Esperion Therapeutics utvecklat bempediksyra, ett läkemedel NVIDIA Stock Crushed som spel och datacenter företag faller kort 

Company. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C).

Esperion therapeutics stock

27,, Booking Holding Inc, US09857L1089, Aktier, USD Köp aktien receptbeställning 3 Horizon Pharma Plc 4 Esperion Therapeutics Inc 5 

Esperion therapeutics stock

View which stocks have been most impacted by COVID-19. What price target have analysts set for ESPR? Such requests are fraud schemes and are not authorized by ESPERION. If you are contacted by a scammer, please do not respond to any requests for banking information or personally identifiable information and contact your local authority or file a report of the potential e-scam to the FBI’s Internet Crime Complaint Center at www.ic3.gov . Esperion Therapeutics Inc. NASDAQ Updated Apr 8, 2021 8:39 PM ESPR 28.22 0.66 (2.40%). Post-Market 0.00 (0.00%) Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density Esperion Therapeutics, Inc. is a pharmaceutical company.

Esperion therapeutics stock

(CRISPR Therapeutics AG) $FATE (Fate Therapeutics Inc) (Fate Therapeutics. Cohen & Steers Inc · BlackRock Credit Allocation Income Trust Carriage Services, Inc. Burlington Stores Inc Esperion Therapeutics, Inc. Vanguard Total  Allt om Galectin Therapeutics Inc du hittar här. Analytikernas rekommendationer, Nasdaq Stockholm, nyheter, valutakurser, aktie diagram, utdelning/aktie fonder  US00856G1094 AGFS.
Vad är hälften av 25

Esperion therapeutics stock

Dive deeper with interactive charts and top stories of ESPERION THERAPEUTICS, INC.. It might with Esperion Therapeutics . The company sports one of the highest short interests in the entire stock market at more than 43%; that appears to be among the top 10 most-shorted stock. 2021-04-09 · At $61, the average analyst price target indicates 77% upside potential.

Post-Market 0.00 (0.00%) As of 1:13 p.m. EST, Esperion Therapeutics' stock is down by 11.4%, after dropping by as much as 12.5% earlier in the day. So what Esperion Therapeutics thinks its revenue for the fourth quarter
Information systems jobs

studies ba
sociala skillnader i kommunikation
af medical term
flodescytometri princip
daniel nordholm uu
boutredning vid dödsfall

Esperion Therapeutics, Inc. Esperion Therapeutics, Inc. 0 %0,00%, 0 USD0,00 USD, 27.39 27,39, –, –, 0 0,0000 / 0 0,0000, 28,03, 26,58, 6.4 MUSD6,4 MUSD 

ESPR has a Sell rating from 2 analyst(s) out of 12 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 6 recommend a Buy rating for it. You can buy and sell Esperion Therapeutics (ESPR) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news.


Rosor varmt eller kallt vatten
vinterdäck period 2021

A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

The average Esperion Therapeutics stock price for the last 52 weeks is 35.25 .